Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study

European Journal of Cardio-thoracic Surgery

Volumn 36, Issue 5, 2009, Pages 856-862

  Firanescu, Cristina E ^a   Martens, Elisabeth J ^a,b   Schönberger, Jacques P A M ^a   Soliman Hamad, Mohamed A ^a   van Straten, Albert H M ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Anticoagulation; Blood; Blood transfusion; Cardiopulmonary bypass; Clopidogrel

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FRESH FROZEN PLASMA;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

AGED; BLOOD COMPONENT TRANSFUSION; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TICLOPIDINE;

EID: 70349917428     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.05.032     Document Type: Article

References (25)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 324 7329 (2002) 71-86
2. Dacey L.J., Munoz J.J., Johnson E.R., Leavitt B.J., Maloney C.T., Morton J.R., Olmstead E.M., Birkmeyer J.D., O'Connor G.T., and Northern New England Cardiovascular Disease Study Group. Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 70 6 (2000) 1986-1990
3. Mangano D.T., and Multicenter Study of Perioperative Ischemia Research Group. Aspirin and mortality from coronary bypass surgery. N Engl J Med 347 17 (2002) 1309-1317
4. Daly D.J., Myles P.S., Smith J.A., Knight J.L., Clavisi O., Bain D.L., Glew R., Gibbs N.M., Merry A.E., and ANZCA Trials Group. Anticoagulation, bleeding and blood transfusion practices in Australasian cardiac surgical practice. Anaesth Intensive Care 35 5 (2007) 760-768
5. Sun J.C., Whitlock R., Cheng J., Eikelboom J.W., Thabane L., Crowther M.A., and Teoh K.H. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J 29 8 (2008) 1057-1071
6. Alghamdi A.A., Moussa F., and Fremes S.E. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg 22 3 (2007) 247-256
7. Peters R.J., Mehta S.R., Fox K.A., Zhao F., Diaz R., Commerford P.J., Valentin V.A., Yusuf S., and Clopidogrel in unstable angina to prevent re current events (CURE) trial investigators. Effects of aspirin dose when used alone or in combination with acute coronary syndromes: Observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation 108 14 (2003) 1682-1687
8. Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., Topol E.J., and CREDO Investigators. Clopidogrel for the Reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. J Am Med Assoc 288 19 (2002) 2411-2420
9. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 9038 (1996) 1329-1339
10. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., Leys D., Matias-Guiu J., Rupprecht H.J., and MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 9431 (2004) 331-337
11. Chen Z.M., Jiang L.X., Chen Y.P., Xie J.X., Pan H.C., Peto R., Collins R., Liu L.S., and COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 9497 (2005) 1607-1621
12. Sabatine M.S., Cannon C.P., Gibson C.M., López-Sendón J.L., Montalescot G., Theroux P., Claeys M.J., Cools F., Hill K.A., Skene A.M., McCabe C.H., Braunwald E., and CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 12 (2005) 1179-1189
13. Chen L., Bracey A.W., Radovancevic R., Cooper Jr. J.R., Collard C.D., Vaughn W.K., and Nussmeier N.A. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 128 3 (2004) 425-431
14. Chu M.W., Wilson S.R., Novick R.J., Stitt L.W., and Quantz M.A. Does clopidogrel increase blood loss following coronary artery bypass surgery?. Ann Thorac Surg 78 5 (2004) 1536-1541
15. Hongo R.H., Ley J., Dick S.E., and Yee R.R. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40 July (2) (2002) 231-237
16. Yende S., and Wunderink R.G. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 29 12 (2001) 2271-2275
17. Ray J.G., Deniz S., Olivieri A., Pollex E., Vermeulen M.J., Alexander K.S., Cain D.J., Cybulsky I., and Hamielec C.M. Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovasc Disord 3 (2003) 3
18. Stein P.D., Schünemann H.J., Dalen J.E., and Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 3 Suppl. (2004) 600S-608S
19. Kunadian B., Thornley A.R., Babu T.N., and Dunning J. Should high risk patients receive clopidogrel as well as aspirin post coronary arterial bypass grafting?. Interact Cardiovasc Thorac Surg 5 6 (2006) 755-760
20. von Heymann C., Redlich U., Moritz M., Sander M., Vargas Hein O., Grubitzsch H., Konertz W.F., and Spies C. Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. Thorac Cardiovasc Surg 53 6 (2005) 341-345
21. Kang W., Theman T.E., Reed III J.F., Stoltzfus J., and Weger N. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery. J Surg Educ 64 2 (2007) 88-92
22. Karabulut H., Toraman F., Evrenkaya S., Goksel O., Tarcan S., and Alhan C. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur J Cardiothorac Surg 25 3 (2004) 419-423
23. Picker S.M., Kaleta T., Hekmat K., Kampe S., and Gathof B.S. Antiplatelet therapy preceding coronary artery surgery: implications for bleeding, transfusion requirements and outcome. Eur J Anaesthesiol 24 4 (2007) 332-339
24. Schönberger J.P., Everts P.A., Ercan H., Bredée J.J., Bavinck J.H., Berreklouw E., and Wildevuur C.R. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. Ann Thorac Surg 54 6 (1992) 1172-1176
25. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 3 (2004) 442-448